Suppr超能文献

走向症状性子宫内膜异位症的综合管理:超越药物治疗与手术治疗的二分法

Towards comprehensive management of symptomatic endometriosis: beyond the dichotomy of medical versus surgical treatment.

作者信息

Mijatovic Velja, Vercellini Paolo

机构信息

Department of Gynaecology & Reproductive Medicine, Academic Endometriosis Center, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Department of Clinical Sciences and Community Health, Università degli Studi and Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

出版信息

Hum Reprod. 2024 Mar 1;39(3):464-477. doi: 10.1093/humrep/dead262.

Abstract

Except when surgery is the only option because of organ damage, the presence of suspicious lesions, or the desire to conceive, women with endometriosis-associated pain often face a choice between medical and surgical treatment. In theory, the description of the potential benefits and potential harms of the two alternatives should be standardized, unbiased, and based on strong evidence, enabling the patient to make an informed decision. However, doctor's opinion, intellectual competing interests, local availability of specific services and (mis)information obtained from social media, and online support groups can influence the type of advice given and affect patients' choices. This is compounded by the paucity of robust data from randomized controlled trials, and the anxiety of distressed women who are eager to do anything to alleviate their disabling symptoms. Vulnerable patients are more likely to accept the suggestions of their healthcare provider, which can lead to unbalanced and physician-centred decisions, whether in favour of either medical or surgical treatment. In general, treatments should be symptom-orientated rather than lesion-orientated. Medical and surgical modalities appear to be similarly effective in reducing pain symptoms, with medications generally more successful for severe dysmenorrhoea and surgery more successful for severe deep dyspareunia caused by fibrotic lesions infiltrating the posterior compartment. Oestrogen-progestogen combinations and progestogen monotherapies are generally safe and well tolerated, provided there are no major contraindications. About three-quarters of patients with superficial peritoneal and ovarian endometriosis and two-thirds of those with infiltrating fibrotic lesions are ultimately satisfied with their medical treatment although the remainder may experience side effects, which may result in non-compliance. Surgery for superficial and ovarian endometriosis is usually safe. When fibrotic infiltrating lesions are present, morbidity varies greatly depending on the skill of the individual surgeon, the need for advanced procedures, such as bowel resection and ureteral reimplantation, and the availability of expert colorectal surgeons and urologists working together in a multidisciplinary approach. The generalizability of published results is adequate for medical treatment but very limited for surgery. Moreover, on the one hand, hormonal drugs induce disease remission but do not cure endometriosis, and symptom relapse is expected when the drugs are discontinued; on the other hand, the same drugs should be used after lesion excision, which also does not cure endometriosis, to prevent an overall cumulative symptom and lesion recurrence rate of 10% per postoperative year. Therefore, the real choice may not be between medical treatment and surgery, but between medical treatment alone and surgery plus postoperative medical treatment. The experience of pain in women with endometriosis is a complex phenomenon that is not exclusively based on nociception, although the role of peripheral and central sensitization is not fully understood. In addition, trauma, and especially sexual trauma, and pelvic floor disorders can cause or contribute to symptoms in many individuals with chronic pelvic pain, and healthcare providers should never take for granted that diagnosed or suspected endometriosis is always the real, or the sole, origin of the referred complaints. Alternative treatment modalities are available that can help address most of the additional causes contributing to symptoms. Pain management in women with endometriosis may be more than a choice between medical and surgical treatment and may require comprehensive care by a multidisciplinary team including psychologists, sexologists, physiotherapists, dieticians, and pain therapists. An often missing factor in successful treatment is empathy on the part of healthcare providers. Being heard and understood, receiving simple and clear explanations and honest communication about uncertainties, being invited to share medical decisions after receiving detailed and impartial information, and being reassured that a team member will be available should a major problem arise, can greatly increase trust in doctors and transform a lonely and frustrating experience into a guided and supported journey, during which coping with this chronic disease is gradually learned and eventually accepted. Within this broader scenario, patient-centred medicine is the priority, and whether or when to resort to surgery or choose the medical option remains the prerogative of each individual woman.

摘要

除因器官损伤、存在可疑病变或有生育意愿而手术成为唯一选择的情况外,患有子宫内膜异位症相关疼痛的女性通常面临药物治疗和手术治疗之间的抉择。理论上,两种治疗方案的潜在益处和潜在危害的描述应标准化、无偏见且基于有力证据,使患者能够做出明智的决定。然而,医生的意见、学术利益冲突、当地特定服务的可及性以及从社交媒体和在线支持小组获取的(错误)信息,都会影响所提供建议的类型并影响患者的选择。随机对照试验的可靠数据匮乏,以及痛苦的女性急于采取任何措施缓解致残症状所带来的焦虑,使情况更加复杂。脆弱的患者更有可能接受医疗服务提供者的建议,这可能导致不平衡且以医生为中心的决策,无论是倾向于药物治疗还是手术治疗。一般来说,治疗应以症状为导向而非以病变为导向。药物和手术方式在减轻疼痛症状方面似乎同样有效,药物通常对严重痛经更有效,而手术对由浸润后盆腔的纤维化病变引起的严重深部性交困难更有效。雌激素 - 孕激素联合用药和孕激素单一疗法通常安全且耐受性良好,前提是没有重大禁忌证。大约四分之三的浅表腹膜和卵巢子宫内膜异位症患者以及三分之二有浸润性纤维化病变的患者最终对药物治疗感到满意,尽管其余患者可能会出现副作用,这可能导致治疗依从性不佳。浅表和卵巢子宫内膜异位症的手术通常是安全的。当存在纤维化浸润性病变时,发病率差异很大,这取决于个体外科医生的技术、是否需要诸如肠道切除和输尿管再植等高级手术,以及是否有专家结直肠外科医生和泌尿外科医生以多学科方式共同协作。已发表结果的普遍性对于药物治疗而言足够,但对于手术治疗则非常有限。此外,一方面,激素药物可诱导疾病缓解但不能治愈子宫内膜异位症,停药后症状预计会复发;另一方面,病变切除后也应使用同样的药物,这同样不能治愈子宫内膜异位症,以防止术后每年总体累积症状和病变复发率达到10%。因此,真正的选择可能不是在药物治疗和手术治疗之间,而是在单纯药物治疗与手术加术后药物治疗之间。子宫内膜异位症女性的疼痛体验是一个复杂的现象,虽然外周和中枢敏化的作用尚未完全了解,但它并非仅基于伤害感受。此外,创伤,尤其是性创伤和盆底功能障碍,可导致或促成许多慢性盆腔疼痛个体的症状,医疗服务提供者绝不能想当然地认为已确诊或疑似的子宫内膜异位症总是所提及症状的真正或唯一根源。有其他治疗方式可帮助解决导致症状的大多数其他原因。子宫内膜异位症女性的疼痛管理可能不仅仅是在药物治疗和手术治疗之间做出选择,可能需要包括心理学家、性学家、物理治疗师、营养师和疼痛治疗师在内的多学科团队提供全面护理。成功治疗中常常缺失的一个因素是医疗服务提供者的同理心。被倾听和理解、得到关于不确定性的简单明了的解释和坦诚沟通、在收到详细且公正的信息后被邀请参与医疗决策,以及得到保证在出现重大问题时会有团队成员提供帮助,这些都可以极大地增强对医生的信任,并将孤独且令人沮丧的经历转变为一段有引导和支持的旅程,在此过程中逐渐学会应对这种慢性病并最终接受它。在这个更广泛的背景下,以患者为中心的医疗是首要任务,是否以及何时诉诸手术或选择药物治疗方案仍然是每位女性的特权。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验